Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preferences Of Patients And Oncologists For The Characteristics Of The Treatment For RCC In Spain And Portugal

NCT05168436 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT05168436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05168436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preferences Of Patients And Oncologists For The Characteristics Of The Treatment For RCC In Spain And Portugal
Lead sponsor
Bristol-Myers Squibb
Phase
Observational
Overall status
Completed
Start date
August 5, 2019
Completion date
July 13, 2020
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma